Inflammatory disorders

Patient-reported outcome measures may aid psoriasis treatment

(HealthDay)—The use of patient-reported outcome measures (PROMs) to complement clinician-reported outcomes (CROs) may yield important information for assessing disease severity and guiding treatment of psoriasis, according ...

Medications

New drug is gamechanger in psoriasis treatment

A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug.

Inflammatory disorders

Smoking has negative effects for patients with psoriasis

(HealthDay)—For patients with psoriasis, smoking has negative effects, including increased frequency of nail involvement and cardiovascular diseases and higher psoriasis area and severity index, according to a study published ...

Inflammatory disorders

Biologics tied to greater reduction in pediatric psoriasis

(HealthDay)—Biologics seem to be associated with greater reduction in psoriasis severity scores and higher drug survival rates than methotrexate in pediatric patients treated in a real-world setting, according to a study ...

Diseases, Conditions, Syndromes

Psoriasis symptoms, quality of life tied to disease severity

(HealthDay)—Patient-reported symptoms of psoriasis, quality of life, and work productivity worsen with increasing disease severity, as measured by two established clinician assessment tools, according to a study published ...

page 2 from 5